Press Releases
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 6, 2021-- Net Revenues Increased 550% Compared to 2020 Fourth Quarter --
-
Apr 22, 2021-- Conference Call Scheduled for 4:30 p.m. ET --
-
Apr 21, 2021Posters Focus on Perfect-Use Efficacy Data and Sexual Satisfaction and Function Among Women in the Phase 3 AMPOWER Trial
-
Mar 17, 2021- Over 2,400 Phexxi units dispensed in February 2021, up 30% from prior month -
-
Mar 4, 2021-- Phexxi® (lactic acid, citric acid and potassium bitartrate) vaginal gel prescriptions growing month over month, catalyzed by "Get Phexxi" Direct-to-Consumer (DTC) Campaign launched February 14th --
-
Feb 18, 2021-- Conference Call Scheduled for 4:30 p.m. ET --
-
Feb 16, 2021Marketing campaign includes the brand's first-ever commercial spot introducing women to a birth control that puts them in control of their body, their sex life, and their pregnancy prevention.
-
Feb 4, 2021Collaboration will provide resources about Phexxi® contraceptive vaginal gel to oncologists, pharmacists and associated healthcare providers
-
Jan 12, 2021Evofem honored amongst best companies globally for outstanding innovation with first-in-class non-hormonal prescription contraceptive vaginal gel, Phexxi®
-
Dec 22, 2020Approximately 25 Million Adult Women Covered by Medicaid
-
Dec 17, 2020High Level of Interest from Clinical Sites Seeking to Participate in EVOGUARD Trial
-
Nov 9, 2020Launched Phexxi™ (lactic acid, citric acid, potassium bitartrate) in U.S. for Hormone-free Contraception
-
Oct 27, 2020-- Conference Call Scheduled for 5:00 p.m. ET --
-
Oct 26, 2020- Live moderated video webcast discussion with members of Evofem management and Key Opinion Leader Patty Cason, RN, MS, FNP-BC, on Thursday, October 29th at 2:00 p.m. ET -